BFRI: Biofrontera Inc. Stocks News on July 16, 2025

BFRI

MT Newswires

a month ago

Biofrontera Inc. Confirms Talks on Merger, Licensing Changes with Biofrontera AG

BIOFRONTERA INC. IS NEGOTIATING FUNDAMENTAL CHANGES TO ITS COOPERATION WITH BIOFRONTERA AG

BFRI

GlobeNewswire

a month ago

BIOFRONTERA INC. IS NEGOTIATING FUNDAMENTAL CHANGES TO ITS COOPERATION WITH BIOFRONTERA AG

Biofrontera Inc. Announces Patent for Propylene Glycol-Free Formula of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% Now Listed in FDA Orange Book

BFRI

GlobeNewswire

a month ago

Biofrontera Inc. Announces Patent for Propylene Glycol-Free Formula of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% Now Listed in FDA Orange Book

BFRI

GuruFocus.com

2 months ago

Biofrontera Inc (BFRI) Q1 2025 Earnings Call Highlights: Revenue Growth and Strategic ...

BFRI

Thomson Reuters StreetEvents

2 months ago

Q1 2025 Biofrontera Inc Earnings Call

Biofrontera Inc. Reports First Quarter 2025 Financial Results and Provides a Business Update

BFRI

GlobeNewswire

2 months ago

Biofrontera Inc. Reports First Quarter 2025 Financial Results and Provides a Business Update

Biofrontera Inc. Announces New Patent Protection on Ameluz® until 2043 and the Completion of Patient Enrollment in Phase 2b Study of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% for the Treatment of Moderate to Severe Acne Vulgaris

BFRI

GlobeNewswire

2 months ago

Biofrontera Inc. Announces New Patent Protection on Ameluz® until 2043 and the Completion of Patient Enrollment in Phase 2b Study of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% for the Treatment of Moderate to Severe Acne Vulgaris

Biofrontera Inc. to Report First Quarter FY 2025 Financial Results on May 15, 2025

BFRI

ACCESS Newswire

2 months ago

Biofrontera Inc. to Report First Quarter FY 2025 Financial Results on May 15, 2025

Biofrontera and Almirall Launch the Hats On Challenge to Raise Awareness and Support for Actinic Keratosis

BFRI

GlobeNewswire

2 months ago

Biofrontera and Almirall Launch the Hats On Challenge to Raise Awareness and Support for Actinic Keratosis

Biofrontera Full Year 2024 Earnings: Misses Expectations

BFRI

Simply Wall St.

4 months ago

Biofrontera Full Year 2024 Earnings: Misses Expectations

BFRI

GuruFocus.com

4 months ago

Biofrontera Inc (BFRI) Q4 2024 Earnings Call Highlights: Record Revenue Growth Amidst Financial ...

BFRI

Thomson Reuters StreetEvents

4 months ago

Q4 2024 Biofrontera Inc Earnings Call

Biofrontera Inc. Reports Record Fiscal Year 2024 Financial Results and Provides a Business Update

BFRI

GlobeNewswire

4 months ago

Biofrontera Inc. Reports Record Fiscal Year 2024 Financial Results and Provides a Business Update

Biofrontera Inc. Announces Completion of Patient Enrollment in Phase 3 Study of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% for the Treatment of Actinic Keratoses on the Extremities, Neck and Trunk

BFRI

GlobeNewswire

4 months ago

Biofrontera Inc. Announces Completion of Patient Enrollment in Phase 3 Study of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% for the Treatment of Actinic Keratoses on the Extremities, Neck and Trunk

Biofrontera Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on March 21, 2025

BFRI

GlobeNewswire

4 months ago

Biofrontera Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on March 21, 2025

BFRI

Simply Wall St.

5 months ago

When Will Biofrontera Inc. (NASDAQ:BFRI) Turn A Profit?

Biofrontera Inc. Announces Achievement of Key Milestone In Phase 3 Study Of Ameluz®-Photodynamic Therapy (PDT) In The Treatment Of Superficial Basal Cell Carcinoma (sBCC)

BFRI

GlobeNewswire

6 months ago

Biofrontera Inc. Announces Achievement of Key Milestone In Phase 3 Study Of Ameluz®-Photodynamic Therapy (PDT) In The Treatment Of Superficial Basal Cell Carcinoma (sBCC)

Biofrontera Inc. Announces 100 RhodoLED® XL Machines Now Placed in US Market

BFRI

GlobeNewswire

7 months ago

Biofrontera Inc. Announces 100 RhodoLED® XL Machines Now Placed in US Market

Biofrontera Inc. to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference

BFRI

ACCESSWIRE

7 months ago

Biofrontera Inc. to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference

Biofrontera Inc. Closes a $4.2 Million Senior Secured Convertible Note

BFRI

GlobeNewswire

8 months ago

Biofrontera Inc. Closes a $4.2 Million Senior Secured Convertible Note

BFRI

GuruFocus.com

8 months ago

Biofrontera Inc (BFRI) Q3 2024 Earnings Call Highlights: Strategic Advancements Amidst Revenue ...

BFRI

Zacks

8 months ago

Biofrontera Inc. (BFRI) Reports Q3 Loss, Lags Revenue Estimates

Biofrontera Inc. Reports Third Quarter and Nine-Month 2024 Financial Results and Provides Business Update

BFRI

GlobeNewswire

8 months ago

Biofrontera Inc. Reports Third Quarter and Nine-Month 2024 Financial Results and Provides Business Update

Biofrontera Inc. to Report Third Quarter Financial Results on November 13, 2024

BFRI

ACCESSWIRE

8 months ago

Biofrontera Inc. to Report Third Quarter Financial Results on November 13, 2024

Biofrontera Inc. Announces Highly Significant Results In Phase 3 Study Of Ameluz®-Photodynamic Therapy (PDT) Regarding The Treatment Of Superficial Basal Cell Carcinoma (sBCC)

BFRI

GlobeNewswire

8 months ago

Biofrontera Inc. Announces Highly Significant Results In Phase 3 Study Of Ameluz®-Photodynamic Therapy (PDT) Regarding The Treatment Of Superficial Basal Cell Carcinoma (sBCC)

Rosalind Advisors, Inc. Reduces Stake in Biofrontera Inc

BFRI

GuruFocus.com

9 months ago

Rosalind Advisors, Inc. Reduces Stake in Biofrontera Inc

Biofrontera Inc. Announces Database Lock Of Phase 3 Study Of Ameluz®-Photodynamic Therapy (PDT) In The Treatment Of Superficial Basal Cell Carcinoma (sBCC)

BFRI

GlobeNewswire

9 months ago

Biofrontera Inc. Announces Database Lock Of Phase 3 Study Of Ameluz®-Photodynamic Therapy (PDT) In The Treatment Of Superficial Basal Cell Carcinoma (sBCC)

BFRI

GuruFocus.com

9 months ago

Biofrontera Inc (BFRI) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

FDA Approves Use of Up To Three Tubes of Biofrontera Inc.’s Ameluz (aminolevulinic acid HCI) Topical Gel, 10% In One Treatment

BFRI

GlobeNewswire

9 months ago

FDA Approves Use of Up To Three Tubes of Biofrontera Inc.’s Ameluz (aminolevulinic acid HCI) Topical Gel, 10% In One Treatment

Biofrontera to Present at the 3rd Annual ROTH Healthcare Opportunities Conference

BFRI

ACCESSWIRE

10 months ago

Biofrontera to Present at the 3rd Annual ROTH Healthcare Opportunities Conference

Biofrontera Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

BFRI

Simply Wall St.

a year ago

Biofrontera Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Biofrontera Inc. Reports Second Quarter 2024 Financial Results and Provides a Business Update

BFRI

GlobeNewswire

a year ago

Biofrontera Inc. Reports Second Quarter 2024 Financial Results and Provides a Business Update

Biofrontera Inc. to Report Second Quarter Financial Results on August 14, 2024

BFRI

ACCESSWIRE

a year ago

Biofrontera Inc. to Report Second Quarter Financial Results on August 14, 2024

BFRI

Simply Wall St.

a year ago

When Will Biofrontera Inc. (NASDAQ:BFRI) Become Profitable?

Biofrontera Announces the Launch of a New, FDA-Approved Red Light Source, the RhodoLED® XL Lamp

BFRI

GlobeNewswire

a year ago

Biofrontera Announces the Launch of a New, FDA-Approved Red Light Source, the RhodoLED® XL Lamp

Biofrontera Inc. Reports First Quarter 2024 Financial Results and Provides a Business Update

BFRI

ACCESSWIRE

a year ago

Biofrontera Inc. Reports First Quarter 2024 Financial Results and Provides a Business Update

Biofrontera Inc. to Report First Quarter 2024 Financial Results on May 15, 2024

BFRI

ACCESSWIRE

a year ago

Biofrontera Inc. to Report First Quarter 2024 Financial Results on May 15, 2024

Biofrontera Announces Achievement of Two Milestones Associated with Series B-3 Convertible Preferred Stock Warrants

BFRI

ACCESSWIRE

a year ago

Biofrontera Announces Achievement of Two Milestones Associated with Series B-3 Convertible Preferred Stock Warrants

Biofrontera Inc. Announces 2024 Annual Meeting of Stockholders and Deadlines for Submission of Stockholder Proposals

BFRI

ACCESSWIRE

a year ago

Biofrontera Inc. Announces 2024 Annual Meeting of Stockholders and Deadlines for Submission of Stockholder Proposals

BFRI

Insider Monkey

a year ago

Biofrontera Inc. (NASDAQ:BFRI) Q4 2023 Earnings Call Transcript

BFRI

Thomson Reuters StreetEvents

a year ago

Q4 2023 Biofrontera Inc Earnings Call

CORRECTION: Biofrontera Inc. Reports Record Fiscal Year 2023 Financial Results and Provides a Business Update

BFRI

ACCESSWIRE

a year ago

CORRECTION: Biofrontera Inc. Reports Record Fiscal Year 2023 Financial Results and Provides a Business Update

BFRI

ACCESSWIRE

a year ago

Biofrontera Inc. Reports Record Fiscal Year 2023 Financial Results and Provides a Business Update

Biofrontera Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on March 15, 2024

BFRI

ACCESSWIRE

a year ago

Biofrontera Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on March 15, 2024

Biofrontera Inc. Announces Closing of Private Placement of up to $16.0 Million Priced at Market per Nasdaq Rules

BFRI

ACCESSWIRE

a year ago

Biofrontera Inc. Announces Closing of Private Placement of up to $16.0 Million Priced at Market per Nasdaq Rules

Biofrontera Inc. Announces Restructuring of Supply Agreement with Biofrontera AG

BFRI

ACCESSWIRE

a year ago

Biofrontera Inc. Announces Restructuring of Supply Agreement with Biofrontera AG

Biofrontera Inc. Announces Private Placement of Up To $16.0 Million Priced at Market per Nasdaq Rules

BFRI

ACCESSWIRE

a year ago

Biofrontera Inc. Announces Private Placement of Up To $16.0 Million Priced at Market per Nasdaq Rules

Biofrontera Inc. Announces FDA Filing of Supplemental New Drug Application for Ameluz(R) to Permit Up to Three Tubes Per Use

BFRI

ACCESSWIRE

a year ago

Biofrontera Inc. Announces FDA Filing of Supplemental New Drug Application for Ameluz(R) to Permit Up to Three Tubes Per Use

Saviynt Implements Bridgeline’s HawkSearch

BFRI

GlobeNewswire

a year ago

Saviynt Implements Bridgeline’s HawkSearch

BFRI

Simply Wall St.

a year ago

Biofrontera Inc. (NASDAQ:BFRI): Is Breakeven Near?

Signing Day Sports Announces More than Five-Fold Increase in Paid Subscribers on its App in 2023

BFRI

GlobeNewswire

a year ago

Signing Day Sports Announces More than Five-Fold Increase in Paid Subscribers on its App in 2023

WAVE Charging Sets Industry Milestone with First-Ever OEM-Approved Commercial Wireless Charging Integration in Kenworth's Class 6 Electric Trucks

BFRI

GlobeNewswire

a year ago

WAVE Charging Sets Industry Milestone with First-Ever OEM-Approved Commercial Wireless Charging Integration in Kenworth's Class 6 Electric Trucks

Jayud Announces Entry into Agreements to Acquire Two International Logistics Companies, Embarking on an Acquisition Strategy to Expand Service Offerings and Geographic Footprint

BFRI

PR Newswire

a year ago

Jayud Announces Entry into Agreements to Acquire Two International Logistics Companies, Embarking on an Acquisition Strategy to Expand Service Offerings and Geographic Footprint

Dividend Challengers List Ranked By Yield: Top 30

BFRI

Insider Monkey

a year ago

Dividend Challengers List Ranked By Yield: Top 30

Mesoblast (MESO) Up on Rare Pediatric Disease Tag for Heart Drug

BFRI

Zacks

a year ago

Mesoblast (MESO) Up on Rare Pediatric Disease Tag for Heart Drug

BFRI

Zacks

a year ago

Zacks Industry Outlook Highlights NetScout, NETGEAR and Lantronix

Epsilon Energy (NASDAQ:EPSN) Is Experiencing Growth In Returns On Capital

BFRI

Simply Wall St.

a year ago

Epsilon Energy (NASDAQ:EPSN) Is Experiencing Growth In Returns On Capital

Labor cost is the elephant in the room for restaurant chains in 2024

BFRI

Yahoo Finance

2 years ago

Labor cost is the elephant in the room for restaurant chains in 2024

Q3 Earnings Roundup: ON24 (NYSE:ONTF) And The Rest Of The Sales And Marketing Software Segment

BFRI

StockStory

2 years ago

Q3 Earnings Roundup: ON24 (NYSE:ONTF) And The Rest Of The Sales And Marketing Software Segment

Biofrontera Inc. Announces Preliminary Revenues for the Fourth Quarter and Full Year 2023

BFRI

ACCESSWIRE

2 years ago

Biofrontera Inc. Announces Preliminary Revenues for the Fourth Quarter and Full Year 2023

$SELLAS Life Sciences Receives FDA Fast Track Designation for SLS009 for Treatment of Relapsed/Refractory Acute Myeloid Leukemia and Provides Updated Data for Phase 2a Study of SLS009 in Relapsed/Refractory Acute Myeloid Leukemia Patients$

BFRI

GlobeNewswire

2 years ago

SELLAS Life Sciences Receives FDA Fast Track Designation for SLS009 for Treatment of Relapsed/Refractory Acute Myeloid Leukemia and Provides Updated Data for Phase 2a Study of SLS009 in Relapsed/Refractory Acute Myeloid Leukemia Patients

Airgain Announces AirgainConnect™ Fleet: an Innovative Roof-Mounted 5G Vehicle Gateway

BFRI

Business Wire

2 years ago

Airgain Announces AirgainConnect™ Fleet: an Innovative Roof-Mounted 5G Vehicle Gateway

Detroit, Los Angeles Drive Demand for 2024 NFL Playoff Tickets, Says TicketSmarter

BFRI

GlobeNewswire

2 years ago

Detroit, Los Angeles Drive Demand for 2024 NFL Playoff Tickets, Says TicketSmarter

Casa Systems Appoints Former Google Executive Santanu Dasgupta as Chief Technology Officer

BFRI

GlobeNewswire

2 years ago

Casa Systems Appoints Former Google Executive Santanu Dasgupta as Chief Technology Officer

Sphere 3D Corp. Provides December 2023 Production and Operation Updates

BFRI

Newsfile

2 years ago

Sphere 3D Corp. Provides December 2023 Production and Operation Updates

Signing Day Sports Commences Collaboration as the Exclusive Recruiting Platform Provider for Elite Development Program (EDP Soccer)

BFRI

GlobeNewswire

2 years ago

Signing Day Sports Commences Collaboration as the Exclusive Recruiting Platform Provider for Elite Development Program (EDP Soccer)

Insiders Of HeartBeam Are Up 49% On Their US$2.89m Purchase

BFRI

Simply Wall St.

2 years ago

Insiders Of HeartBeam Are Up 49% On Their US$2.89m Purchase

Progressive Care's PharmcoRx Pharmacies Expands Medicare Advantage Over-the-Counter Benefits Acceptance Program Through New Agreement with ProHealth Connect

BFRI

PR Newswire

2 years ago

Progressive Care's PharmcoRx Pharmacies Expands Medicare Advantage Over-the-Counter Benefits Acceptance Program Through New Agreement with ProHealth Connect

3 Meme Stocks I Wouldn’t Touch With a 10-Foot Pole

BFRI

InvestorPlace

2 years ago

3 Meme Stocks I Wouldn’t Touch With a 10-Foot Pole

BFRI

News Direct

2 years ago

Revolutionizing trucking safety: Cepton's LiDAR technology takes the wheel for semi safety

BFRI

News Direct

2 years ago

Transformative tech: Cepton's Mitch Hourtienne talks future of LiDAR integration in vehicles

The Real Brokerage to Present at Upcoming Investor Conferences

BFRI

Business Wire

2 years ago

The Real Brokerage to Present at Upcoming Investor Conferences

PharmcoRx Pharmacy Launches Mark Cuban Cost Plus Drug Program Expanding Its In-Pharmacy Offerings

BFRI

PR Newswire

2 years ago

PharmcoRx Pharmacy Launches Mark Cuban Cost Plus Drug Program Expanding Its In-Pharmacy Offerings

BFRI

Zacks

2 years ago

Biofrontera Inc. (BFRI) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

We're Not Very Worried About CervoMed's (NASDAQ:CRVO) Cash Burn Rate

BFRI

Simply Wall St.

2 years ago

We're Not Very Worried About CervoMed's (NASDAQ:CRVO) Cash Burn Rate

Earnings Release: Here's Why Analysts Cut Their iPower Inc. (NASDAQ:IPW) Price Target To US$1.50

BFRI

Simply Wall St.

2 years ago

Earnings Release: Here's Why Analysts Cut Their iPower Inc. (NASDAQ:IPW) Price Target To US$1.50

Here’s What Led Conestoga Capital Advisors to Sell Nanostring Technologies (NSTG)

BFRI

Insider Monkey

2 years ago

Here’s What Led Conestoga Capital Advisors to Sell Nanostring Technologies (NSTG)

BFRI

Insider Monkey

2 years ago

Biofrontera Inc. (NASDAQ:BFRI) Q3 2023 Earnings Call Transcript

BFRI

Simply Wall St.

2 years ago

Benign Growth For Biofrontera Inc. (NASDAQ:BFRI) Underpins Stock's 50% Plummet

Biofrontera Inc. Reports Third Quarter 2023 Financial Results and Provides a Business Update

BFRI

ACCESSWIRE

2 years ago

Biofrontera Inc. Reports Third Quarter 2023 Financial Results and Provides a Business Update

Cepton, Inc. Reports Third Quarter 2023 Results

BFRI

Business Wire

2 years ago

Cepton, Inc. Reports Third Quarter 2023 Results

BFRI

Zacks

2 years ago

Biofrontera Inc. (BFRI) Upgraded to Buy: Here's What You Should Know

NanoString Technologies to Present Portfolio of Cutting-edge Brain Research and Novel Spatial Biology Applications for Neuroscience

BFRI

Business Wire

2 years ago

NanoString Technologies to Present Portfolio of Cutting-edge Brain Research and Novel Spatial Biology Applications for Neuroscience

BFRI

Thomson Reuters StreetEvents

2 years ago

Q3 2023 Matinas BioPharma Holdings Inc Earnings Call

Matinas BioPharma Holdings Inc (MTNB) Reports Q3 2023 Financial Results and Business Progress

BFRI

GuruFocus.com

2 years ago

Matinas BioPharma Holdings Inc (MTNB) Reports Q3 2023 Financial Results and Business Progress

BFRI

Associated Press Finance

2 years ago

Marin Software: Q3 Earnings Snapshot

BFRI

Business Wire

2 years ago

Marin Software Announces Third Quarter 2023 Financial Results

BFRI

Insider Monkey

2 years ago

Latest Biofrontera Inc. (BFRI) News on July 16, 2025

Share on Social Networks: